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 Precise gene regulation is pivotal for proper development. Dosage 
compensation, a specialized mechanism of chromosome-wide gene regulation, is the 
process by which the expression of genes on the X chromosome are equalized between 
males, which have a single X chromosome and females or hermaphrodites, which have 
two. This process is essential in all organisms where there are two sexes and the two 
sexes have different sex chromosomes, or the same sex chromosomes, but different 
numbers of sex chromosomes.  For example, humans and flies both exist as two sexes 
that have different sex chromosomes.  Males have an X and an Y chromosome, 
whereas, females have two X chromosomes.  Similarly, worms, such as C. elegans also 
exist as two sexes.  C. elegans exist as males and self-fertile hermaphrodites (modified 
females that make sperm for a short period of time before switching to egg production).   
While each of these organisms (humans, flies, and worms) uses dosage compensation 
to equalize the amounts of gene expression between the one X chromosome in males 
and the two X chromosomes in females/hermaphrodites, they have each co-opted a 
different module of genes for dosage compensation which has resulted in three very 
different dosage compensation mechanisms (Plath, et al., 2003; Meller, et al., 2003; 
Meyer and Casson, 1986).   
To better understand how this essential chromosome-wide gene regulation 
process has evolved, characterization and comparison of this process in more closely 
related species is required. An excellent platform for comparison are the two 
Caenorhabditis species, Caenorhabditis briggsae and Caenorhabditis elegans. C. 
elegans and C. briggsae diverged ~15-30 million years ago and their sequence 
divergence is about 0.3 substitutions per site slightly greater than human and mouse 
(Cutter, 2008). These characteristics make these two species an ideal choice. The level 
of divergence is such that you would not necessarily predict complete conservation or 
complete divergence of dosage compensation mechanisms. Rather, you would expect 
the presence of enough differences such that it would further our understanding of 
dosage compensation evolution. 
In C. elegans, dosage compensation has been well characterized.  C. elegans 
dosage compensation is mediated by the developmental switch gene xol-1 (Rhind, et 
al., 1995). The function of xol-1 is conserved between C. elegans and C. briggsae. In 
both species, loss of xol-1 results in male-specific lethality and overexpression results in 
hermaphrodite specific lethality.  To further understand the evolution of xol-1 function, 
we performed a C. briggsae xol-1 suppressor screen. C. briggsae xol-1 suppressors will 
be identified based on their ability to suppress the xol-1 male lethality phenotype. We 
are currently characterizing eight newly identified suppressors and have determined the 
ability of each suppressor to rescue the xol-1 male lethality phenotype.  Male rescue 
percentages for the eight suppressors range from 8% to 30%, suggesting that the eight 
newly identified suppressors are likely to be different.  Next, we will use whole genome 
sequencing to determine the genetic identity of these suppressors.   
We predict that these suppressors will belong to one of two classes: (1) C. 
briggsae homologs of a known C. elegans dosage compensation pathway component 
or (2) novel suppressors. Novel suppressors will represent components of the C. 
briggsae dosage compensation pathway that we are currently unaware of and further 
our understanding of the C. briggsae dosage compensation pathway. Furthermore, 
comparison of the dosage compensation pathways in C. elegans and C. briggsae will 
provide novel insights into the evolution of dosage compensation, an important 
chromosome-wide gene regulation mechanism. 
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